AI Analysis

Generated: 18 weeks ago. (Likely Outdated!)

Hims & Hers Health, Inc. (Ticker: HIMS) is a telehealth company that connects customers with licensed healthcare professionals to get prescriptions, over-the-counter medications, and personal care products delivered directly to their homes. Think of it as a digital health platform where you can get personalized care for various health and wellness needs without leaving your couch.

The Business Model (How They Make Money)

Hims & Hers makes money primarily by selling health and wellness products and services directly to consumers through its online platform. Their core business revolves around a subscription-based model where customers receive ongoing access to medical consultations and treatments for conditions like sexual health, hair loss, hormone health, weight loss, dermatology, and mental health.

In 2025, the company generated a total revenue of $2,347.6 million. The vast majority of this, $2,311.4 million, came from their "Online" segment, which includes all the direct-to-consumer sales through their platform. This shows that their direct online sales are the powerhouse of their business. Their personalized offerings, which are tailored treatment plans developed by healthcare providers, made up over 70% of their U.S. revenue in 2025. The "Hers" brand, focusing on women's health, contributed nearly 40% of their U.S. revenue in 2025, largely driven by weight loss treatments (GLP-1s) and dermatology products.

For the first quarter of 2026, Hims & Hers reported revenue of $608.1 million. The company expects its full-year 2026 revenue to be between $2.8 billion and $3.0 billion.

The Metrics That Matter Most

For Hims & Hers, a company focused on growing its direct-to-consumer health platform, these 3 to 5 metrics are crucial:

  1. Revenue: This metric tells you the total amount of money the company brings in from selling its products and services. For Hims & Hers, strong revenue growth indicates that more people are signing up for their services and that their personalized health offerings are resonating with customers. It's the most direct measure of how much their business is expanding. In 2025, revenue was $2,347.6 million, and for the first quarter of 2026, it was $608.1 million.
  2. Gross Margin: This shows how much profit the company makes from its sales after subtracting the direct costs of providing its services and products. For Hims & Hers, it reflects how efficiently they are delivering their telehealth consultations and medications. A healthy gross margin means they are managing their costs well. The gross margin was 65% in the first quarter of 2026, a decrease from 73% in the first quarter of 2025. This decline is an important trend to watch as it impacts their overall profitability.
  3. Net Income (or Net Loss): This is the company's total profit after all expenses, including operating costs, interest, and taxes, have been paid. It's the ultimate measure of how profitable the business is. For Hims & Hers, seeing whether they are making a profit or a loss, and how that changes over time, is key to understanding their financial health. The company reported a net loss of $92.1 million in the first quarter of 2026, compared to a net income of $49.5 million in the first quarter of 2025. In contrast, for the full year 2025, Hims & Hers had a net income of $128.4 million.
  4. Operating Cashflow: This metric shows the cash generated by the company's regular business activities, before accounting for investments or financing. For Hims & Hers, it indicates how much cash their core operations are actually bringing in, which is vital for funding their growth, paying bills, and potentially expanding without needing to borrow more money. For the full year 2025, net cash provided by operating activities was $300.0 million. In the first quarter of 2026, net cash provided by operating activities was $89.4 million.
  5. Sales & Marketing (S&M) expenses: As a direct-to-consumer company, Hims & Hers relies heavily on advertising and promotions to attract new customers to its platform. This metric tells you how much they are spending to get people to sign up for their services. Watching this expense helps understand how much it costs them to grow their customer base and if those marketing efforts are efficient.

How to Value This Company

For Hims & Hers, the P/Sales (Price-to-Sales Ratio) is the most relevant valuation metric.

Here's why: Hims & Hers is a growing company that has recently reported a net loss in its latest quarter. When a company is still in a growth phase and its profits (net income) might be small or even negative, traditional valuation metrics like the Price-to-Earnings (P/E) ratio aren't very useful because there are no earnings to compare to the stock price.

The P/Sales ratio helps you figure out if the stock is cheap or expensive by comparing the company's total stock market value (its "market capitalization") to its total sales (revenue) over the last year. It essentially tells you how much investors are willing to pay for each dollar of the company's sales. For Hims & Hers, a lower P/Sales ratio compared to its competitors or its own historical average might suggest it's a more attractive investment, indicating that you're paying less for each dollar of revenue the company generates. It's a good way to value companies that are prioritizing expanding their customer base and revenue, even if they aren't consistently profitable yet.

⚠️ Disclaimer: This analysis is generated by AI. stockpicker.tech is not responsible for any mistakes, inaccuracies, or hallucinations. This is for educational purposes only and does not constitute financial advice. Users should always double-check the information and conduct their own research before making investment decisions.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Hims & Hers Health, Inc.

$27.68 -$5.73 (-17.15%)
NYSE · 30 Oct 2026 20:00 UTC
Previous Close
$29.67
Day Range
$26.68$28.75
Year Range
$13.74$48.34
Market Cap
6.23B
AVG Volume
12.08M
Trailing/Forward PE
-45.38/92.79
PEG ratio
0.2
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIMS Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q22.58B
26 Q12.37B
25 Q42.35B
25 Q32.21B
25 Q22.01B
25 Q11.78B
24 Q41.48B
24 Q31.24B
24 Q21.07B
24 Q1959.4M
Net Income (USD) · TTM
-200M-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIMS Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-142.03M
26 Q1-13.23M
25 Q4128.37M
25 Q3133.79M
25 Q2193.6M
25 Q1164.4M
24 Q4126.04M
24 Q3101.26M
24 Q218.1M
24 Q1-2.35M
Operating Income (USD) · TTM
-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIMS Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-92.67M
26 Q131.25M
25 Q4105.61M
25 Q3115.02M
25 Q2125.59M
25 Q1109.9M
24 Q461.9M
24 Q342.91M
24 Q211.98M
24 Q1-8.29M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: HIMS

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 9 Nov 2026.

Hims & Hers Health, Inc.
HIMS
Stockpicker

Video analysis: HIMS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HIMS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.